Holding JMB logoHOLDING JMB

Financial Investment · May 2026

Private credit in Europe: opportunity for patient capital

Bank retrenchment is opening attractive, well-secured lending opportunities for long-term investors.

€1.7tn
Global private credit AUM
8–11%
Target gross yield
< 55%
Target LTV
3–5 yrs
Loan duration
Research Note14 min readHolding JMB Research Office

Executive summary

As banks reduce exposure to mid-market lending, private credit funds and long-term investors are stepping in.

Well-structured loans with strong collateral and covenants offer attractive risk-adjusted returns.

Discipline in underwriting remains the key differentiator in this growing market.

Key takeaways
  • 01As banks reduce exposure to mid-market lending, private credit funds and long-term investors are stepping in.
  • 02Well-structured loans with strong collateral and covenants offer attractive risk-adjusted returns.
  • 03Discipline in underwriting remains the key differentiator in this growing market.
Section 01

Why banks are retreating

Basel III and its final implementation under CRR3 have raised capital requirements for mid-market corporate lending, encouraging banks to reduce balance-sheet exposure.

Non-bank lenders fill this gap with flexible, tailored financing solutions.

Section 02

Underwriting discipline

We focus on senior secured positions, robust maintenance covenants and conservative leverage. Every opportunity undergoes financial, legal and ESG due diligence.

Section 03

Portfolio construction

Diversification across sectors, geographies and vintages limits concentration risk, while active monitoring enables early intervention.

Market data

European private credit AUM (illustrative, €bn)
Allocation by strategy (%)

Source: Holding JMB Research Office. Figures are indicative and for illustration only.

  • AIFM Directive 2011/61/EU
  • CRR3 / Basel III final reform
  • Code monétaire et financier — lending monopoly exceptions
  • SFDR disclosure regulation (EU) 2019/2088

Outlook

Private credit remains an attractive allocation for patient capital, provided underwriting standards are maintained.
Important notice. This publication is issued by HOLDING JMB, SARL à capital variable, RCS Paris 528 403 074, for information purposes only. It does not constitute investment advice, an offer or solicitation to buy or sell any financial instrument. Past performance is not indicative of future results. Figures are indicative and may not reflect actual transactions.